Despite encoding a major type I diabetes autoantigen and given its impact on insulin secretion (Saeki et al., 2002), not a single PTPRN polymorphism has been unambiguously linked to neuroendocrine diseases. This evidence concerns the gene PTPRN and type 1 diabetes mellitus.